9th Nov 2005 07:01
AstraZeneca PLC09 November 2005 ASTRAZENECA COMMENCES PATENT INFRINGEMENT LITIGATION AGAINST TEVA AstraZeneca announced today that it has filed a lawsuit in the United StatesDistrict Court for the District of New Jersey against Teva Pharmaceuticals USA,Inc. and Teva Pharmaceuticals Industries, Ltd. for willful infringement ofAstraZeneca's substance patent protecting Seroquel. The lawsuit is in response to an Abbreviated New Drug Application filed by Tevawith the US Food and Drug Administration regarding Teva's intent to market ageneric version of AstraZeneca's Seroquel (quetiapine fumarate) in the US priorto the expiration of AstraZeneca's Patent No. 4,879,288, which is listed in theFDA's Orange Book and which expires in 2011, subject to any extension. AstraZeneca has full confidence in and will continue vigorously to defend andenforce its intellectual property rights protecting Seroquel. 9 November 2005 Media Enquiries: Edel McCaffrey, Tel: +44 (0) 207 304 5034Steve Brown, Tel: +44 (0) 207 304 5033 Investor Enquiries: Mina Blair, Tel: +44 (0) 207 304 5084Jonathan Hunt, Tel: +44 (0) 207 304 5087Ed Seage, Tel: +1 302 886 4065Jorgen Winroth, Tel + 1 212 579 0506 -Ends- This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca